Advances in Neuroblastoma Research Assoc C/o Garrett Brodeur Md Chop
Nonprofit profile at a glance
- EIN
- 473611221
- IRS 990-EZ coverage
- 2015–2024
- Forms available
- Form 990-EZ 2024
- Location
- Philadelphia, PA, USA
- Phone
- 2155902817
- Rating confidence
- Limited
- Sector
- Cancer Research
Reported finances
- Revenue
- $60,188
- Expenses
- $2,949
- Assets
- $292,842
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
13 people listed
People named in this filing
- GARRETT BRODEUR (SECRETARY-TR)
- GUDRUN SCHLEIERMACHER (PAST PRESIDE)
- ROCHELLE BAGATELL (REGIONAL DIR)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The organization's purpose is to conduct charitable, educational, and scientific activities within the meaning of section 501(c)(3) of the internal revenue code. The organization's primary activity and focus will be to bring scientists and medical practitioners together to promote a greater understanding of neuroblastoma as well as to improve the diagnosis, treatment, and outcome of patients with this form of cancer.
What it reported doing in 2024
Annual meeting to keep scientists and medical practitioners informed about current developments in the field of neuroblastoma research
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 100
- Sustainability: 82
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 95.1%; rating input score 99; 99th percentile among comparable filings
- Total-asset coverage ratio: 99.3; rating input score 99; 99th percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -17.1% per year; rating input score 0; 20th percentile among comparable filings
- Revenue growth: -8.9% per year; rating input score 0; 26th percentile among comparable filings
- Asset growth: 1.8% per year; rating input score 100; 46th percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 13 people listed
- Consistency: 5 of 5 current checks pass
- Schedules: 3 filed schedules
- Filing history: 9 filing years from 2015 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.